Personal Genomics in the Classroom: Students Sequence Themselves
By Monya Baker,
Nature News Blog
| 10. 11. 2012
Medical and graduate students will get the chance to sequence and interpret their own genomes in what is being billed as the first-ever course to offer whole-genome sequencing.
Mount Sinai Medical School in New York is offering an elective course called ‘Practical Analysis of Your Personal Genome’ this year. The goal is to teach upcoming physicians how sequencing information might affect clinical care.
Students can choose to sequence their own or an anonymous genome. This will reveal several million variants, many with known implications for disease and health, and many more with unclear significance. Students may learn their risk for common diseases such as cancer or diabetes and also whether they carry mutations that could cause single-gene disorders in their children.
Mount Sinai will also use questionnaires to find out whether students opting to analyse their own genomes know more about sequencing and how they feel about the utility and psychological impact of whole-genome sequencing. The 20-person class comprises graduate and medical students as well as junior faculty, the school said in an
announcement.
Students analysing their own blood...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...